title: Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease? Part II: Management, prevention and future perspective.
abstract: The management of dementia and mild cognitive impairment (MCI) includes pharmacological, nonpharmacological and caregiver interventions. Acetyl-cholinesterase inhibitors and memantine have a small beneficial effect in mild-to-moderate dementia. Attention is increasingly focused on long-term measures that may prevent, delay or minimize MCI and dementia, including Mediterranean diet, exercise, early active treatment of hypercholesterolaemia hypertension, and diabetes starting in midlife and earlier. High cognitive activity and a high cognitive reserve may prevent or delay the onset of aging-related MCI and dementia. Although the numbers of the elderly with dementia are rapidly increasing worldwide, the incidence of dementia in some countries is decreasing attributable to higher educational levels, decreased vascular risk factors and healthier lifestyles. Prevention of dementia is feasible and reasonable.
authors.forename: Dennis A
authors.initials: DA
authors.lastname: Davey
mesh_terms: D000544:Alzheimer Disease / Q000503:physiopathology / Q000517:prevention & control* / Q000628:therapy*; D000818:Animals; D015140:Dementia, Vascular / Q000503:physiopathology / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
keywords: Alzheimer's disease; cognitive reserve dementia; management; mild cognitive impairment; prevention; vascular dementia